AVBP Stock-Based Compensation
Arrivent Biopharma Inc · Stock-Based Compensation
AVBP Stock-Based Compensation
Latest reported$6.67Mperiod ending
AVBP Quarterly Stock-Based Comp ($113.00K → $6.67M)
Quarterly stock-based compensation
High-resolution chart · PNG
AVBP stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,665,000 | |
| 5,485,000 | |
| 3,222,000 | |
| 3,716,000 | |
| 3,311,000 | |
| 2,271,000 | |
| 952,000 | |
| 866,000 | |
| 765,000 | |
| 625,000 | |
| 319,000 | |
| 217,000 | |
| 193,000 | |
| 166,000 | |
| 113,000 | |
| 113,000 |